Acute Care and Behavioral Health Segment Analysis
UHS
EBITDA & FCF Reconciliation
Nine months
ended September 30,
Twelve months
ended September 30,
Twelve months
ended December 31,
2021
2020
2021
2020
2020
2019
2018
2017
2016
Reconciliationof net income attributable to
UHS to EBITDA, net of NCI
Net income attributable to UHS
Depreciation and amortization
752,466
399,850
635,245
376,563
1,061,174
977,611
943,953
814,854
779,705
752,303
702,409
533.780
625,747
510,493
490,392
453,045
447,765
416,608
Interest expense, net
64,455
86,399
84,341
167,005
106,285
162,733
154,956
145,169
125,053
Provision for income taxes
232,844
204,699
327,488
315,002
299,293
238,794
236,642
363,697
409,187
EBITDA net of NCI
$1,449,615
$1,302,856
$2,006,783
$2,085,365
$1,860,024
$1,706,773
$1,624,348
$1,708,934
$1,653,257
Other (income) expense, net
Increase in DOJ Reserve
(1,575)
8,291
(9.880)
0
0
0
(1,640
0
(14)
(13,162)
(14,219)
0
0
0
10,978
102,327
0
Provision for asset impairment
0
0
0
Adjusted EBITDA net of NCI
$1,448,040
$1,311,147
$1,996,903
97,631
$2,181,356
0
$1,860,010
97,631
$1,802,220
49,310
$1,761,766
0
0
$1,708,934
$1,653,257
Nine months
Twelve months
Free Cash Flow Reconciliation
ended September 30,
ended September 30,
2021
2020
2021
2020
2020
Twelve months
ended December 31,
2019
2018
2017
2016
Cash Flows From Operations
561,675
2,218,157
Less: Capital Expenditures
(666,025)
Less: Distributions to Noncontrolling interests
Less: Regular Dividends
Free Cash Flow
(5,744)
(50,284)
(160,378)
(546,656)
(15,175)
(17,344)
$1,638,982
703,687
(850,676)
(10,374)
(50,284)
($207,647)
2,984.062
2,360,169
1,438,469
1,274,742
1,427,585
1,254,509
(856,831)
(19,384)
(731,307)
(634,095)
(664,962)
(557,506)
(519,939)
(19,805)
(15,859)
(14,595)
(24,713)
(69,583)
(52,394)
(17,344)
(53,003)
(37,342)
(38,211)
(38,875)
$2,055,453
$1,591,713
$735,512
$557,843
$807,155
$626,112
In thousands.
Note: Cash Flow from Operations for the twelve months ended December 31, 2020 includes $698.8mm in Medicare Accelerated payments and deferred government stimulus
grants. Cash Flow from Operations for the nine and twelve months ended September 30, 2021 includes $695mm of repayments of Medicare Accelerated payments.
30View entire presentation